Skip Links

  • Go to homepage [Accesskey '0']
  • Go to content [Accesskey '1']
  • Go to navigation [Accesskey '2']
  • Search site [Accesskey '3']
  • Go to footer links [Accesskey '4']
  • Go to accessibility page [Accesskey '5']
  • About us
  • Patients & carers
  • Health professionals
  • Investors
  • Media Center
  • Contact us
  • Home
  • >
  • Site Map
Neuropharm

Site Map

  • About us
    • History
    • Board of directors
    • Portfolio and pipeline
      • NPL-2008: Autism
      • NPL-2510: Autism Diagnostic
      • Fragile X syndrome
      • Pediatric OCD
      • NPL-2505: Novel reformulation
    • Our strategy and vision
    • Our key strengths
    • Our key relationships
    • Collaborations
    • Corporate governance
  • Patients & carers
    • Autism
      • FAQ
    • Fragile X syndrome
      • FAQ
    • Pediatric OCD
      • FAQ
  • Health professionals
    • Autism
      • Clinical trials
      • What we have accomplished
      • The future
      • Product development
      • FAQs
    • Fragile X syndrome
      • Clinical trials
      • What we have accomplished
      • The future
      • Product development
      • FAQs
    • Pediatric OCD
      • Clinical trials
      • What we have accomplished
      • The future
      • Product development
      • FAQs
    • NPL-2505: Novel reformulation
      • Clinical trials
      • What we have accomplished
      • The future
      • Product development
      • FAQs
  • Investors
    • Share price
    • Financial summary
    • Annual & Interim reports
    • Financial calendar
    • Significant shareholders
    • Advisors
    • IR contacts
    • Compliance information - AIM Rule 26
    • Research notes
  • Media Center
    • News releases
    • Regulatory announcements
    • Email alert request form
  • Contact us

Contact us

  • UK office

Neuropharm Group plc
Fetcham Park House
Lower Road
Leatherhead
Surrey KT22 9HD
United Kingdom

T: +44 (0)1372 371 171

Email: UK office

Site by Radley Yeldar

© Neuropharm Group plc 2010

  • Sitemap
  • Privacy policy
  • Accessibility
  • Useful links
  • Glossary
  • Careers